New Medscape Commentary Video
A Medscape Expert Commentary video about the flu vaccine recommendations for the 2016-2017 season is now available. Updated vaccination recommendations are discussed. CDC expert commentary on Flu Vaccine For People with Egg Allergies and No LAIV (Nasal Spray) Flu Vaccine This Season are also available.
CDC Provides Vaccine Recommendations for the 2016-2017 Influenza Season|
Editor's Note: Don't miss our other reports on the Center for Disease Control and Prevention's (CDC's) influenza vaccine recommendations for 2016-2017, including No LAIV (Nasal Spray) Flu Vaccine This Season and Flu Vaccine for People With Egg Allergies. In addition, please visit our Influenza Resource Center often for updates.
I am Lisa Grohskopf, from CDC's Influenza Division. I am happy to speak with you today as part of the CDC Expert Commentary Series on Medscape. Today I will be highlighting for you the most pertinent information related to 2016-2017 influenza vaccines and CDC's vaccination recommendations.
CDC recommends that everyone aged 6 months or older receive an influenza vaccine every year, by the end of October if possible. However, CDC continues to recommend that influenza vaccination efforts continue as long as influenza viruses are circulating in the community. Significant seasonal influenza virus activity can continue into May, so vaccination later in the season can still provide benefit during most seasons.
One big change for the 2016-2017 season is that only injectable influenza vaccines are recommended for use. Live attenuated influenza vaccine (also known as the nasal spray) isnot recommended for use during 2016-2017 because of concerns about effectiveness.
Recommended 2016-2017 influenza vaccines include a number of inactivated injectable vaccines as well as recombinant influenza vaccine. Both trivalent and quadrivalent injectable vaccines will be available this season. Trivalent vaccines are designed to protect against three different influenza viruses. Quadrivalent influenza vaccines protect against the same three viruses plus an additional B virus from a different lineage of influenza B viruses. No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one licensed, recommended product is otherwise appropriate.
The 2016-2017 vaccine options are listed in the table of US influenza vaccines in Morbidity and Mortality Weekly Report and include the following:
Of note, the composition of this season's vaccines has been updated to better match more recently circulating influenza viruses. Specifically, all of the 2016-2017 vaccines are recommended to include:Continue Reading